Parabilis Medicines
IPOCreating extraordinary medicines
Public · Cambridge, United States · Founded 2021 · $812.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2021
- Business Model
- B2B
- Website
- parabilismed.com
- Total Funding
- $812.0M
- Last Round
- $305.0M Series FJan 2026
- Rounds
- 7
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for people living with cancer and other severe diseases. The company has pioneered a new category of ultra-tunable peptide therapeutics called Helicons, which combine the strengths of small molecules and monoclonal antibodies to achieve outcomes previously considered impossible. Parabilis's custom-built research engine is designed to tackle previously undruggable biology targets, and the company has demonstrated clinical proof-of-concept for its approach. Headquartered in Cambridge, Massachusetts, Parabilis raised $305M in early 2026 to advance its pipeline of Helicon-based cancer therapies.
Summary
Parabilis Medicines is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $812.0M in total across 7 rounds, most recently a $305.0M Series F round in Jan 2026. Investors include RA Capital Management, Janus Henderson Investors and Fidelity Management.
Tech & App Stack
9 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jun 2026
Sign up to see all 8 events
Funding: Seed through Series F. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/parabilis-medicines"><img src="https://indexed.vc/api/badge/company/parabilis-medicines" alt="Parabilis Medicines on Indexed.vc" width="260" height="76" /></a>